Protocol for the CONVERT trial—Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status

INTRODUCTION: Concurrent ONce-daily VErsus twice-daily RadioTherapy (CONVERT) is the only multicentre, international, randomised, phase III trial open in Europe and Canada looking at optimisation of chemoradiotherapy (RT) in limited stage small cell lung cancer (LS-SCLC). Following on from the Turri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Faivre-Finn, Corinne, Falk, Sally, Ashcroft, Linda, Bewley, Michelle, Lorigan, Paul, Wilson, Elena, Groom, Nicki, Snee, Michael, Fournel, Pierre, Cardenal, Felipe, Bezjak, Andrea, Blackhall, Fiona
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4735219/
https://ncbi.nlm.nih.gov/pubmed/26792218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-009849
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados